Neisseria meningitidis: An overview of the carriage state

Journal of Medical Microbiology

Volumn 53, Issue 9, 2004, Pages 821-832

  Yazdankhah, Siamak P ^a   Caugant, Dominique A ^a,b  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CEFACLOR; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; CROSS REACTING ANTIBODY; MENINGOCOCCUS VACCINE; PENICILLIN G; POLYSACCHARIDE VACCINE; RIFAMPICIN;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL MEMBRANE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BACTERIUM CARRIER; CELLULAR IMMUNITY; DISEASE CARRIER; GENOTYPE; HORIZONTAL GENE TRANSFER; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; MEMBRANE STRUCTURE; MENINGOCOCCOSIS; MICROBIAL DIVERSITY; MOLECULAR CLONING; NASOPHARYNX; NEISSERIA; NEISSERIA MENINGITIDIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SPECIES INVASION; STRAIN DIFFERENCE; VACCINATION;

CARRIER STATE; HUMANS; MENINGOCOCCAL INFECTIONS; NASOPHARYNX; NEISSERIA MENINGITIDIS;

EID: 4544256589     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.45529-0     Document Type: Review

References (139)

1. Abramson, J. S. & Spika, J. S. (1985). Persistence of Neisseria meningitidis in the upper respiratory tract after intravenous antibiotic therapy for systemic meningococcal disease. J Infect Dis 151, 370-371.
2. Ala'Aldeen, D. A., Neal, K. R., Ait-Tahar, K., Nguyen-Van-Tam, J. S., English, A., Falla, T. J., Hawkey, P. M. & Slack, R. C. (2000). Dynamics of meningococcal long-term carriage among university students and their implications for mass vaccination. J Clin Microbiol 38, 2311-2316.
3. Andoh, A., Fujiyama, Y., Kimura, T., Uchihara, H., Sakumoto, H., Okabe, H. & Bamaba, T. (1997). Molecular characterization of complement components (C3, C4, and factor B) in human saliva. J Clin Immunol 17, 404-407.
4. Arreaza, L., Salcedo, C., Alcala, B. & Vazquez, J. A. (2002). What about antibiotic resistance in Neisseria lactamica? J Antimicrob Chemother 49, 545-547.
5. Bäckman, A., Orvelid, P., Vazquez, J. A., Sköld, O. & Olcén, P. (2000). Complete sequence of a β-lactamase-encoding plasmid in Neisseria meningitidis. Antimicrob Agents Chemother 44, 210-212.
6. Bitter, W., Koster, M., Latijnhouwers, M., de Cock, H. & Tommassen, J. (1998). Formation of oligomeric rings by XcpQ and PilQ, which are involved in protein transport across the outer membrane of Pseudomonas aeruginosa. Mol Microbiol 27, 209-219.
7. Blackwell, C. C., Weir, D. M., James, V. S., Todd, W. T., Banatvala, N., Chaudhuri, A. K., Gray, H. G., Thomson, E. J. & Fallon, R. J. (1990). Secretor status, smoking and carriage of Neisseria meningitidis. Epidemiol Infect 104, 203-209.
8. Blackwell, C. C., Tzanakaki, G., Kremastinou, J., Weir, D. M., Vakalis, N., Elton, R. A., Mentis, A. & Fatouros, N. (1992). Factors affecting carriage of Neisseria meningitidis among Greek military recruits. Epidemiol Infect 108, 441-448.
9. Brandtzaeg, P., Bjerre, A., Øvstebø, R., Brusletto, B., Joø, G. B. & Kierulf, P. (2001). Neisseria meningitidis lipopolysaccharides in human pathology. J Endotoxin Res 7, 401-420.
10. Broome, C. V. (1986). The carrier state: Neisseria meningitidis. J Antimicrob Chemother 18, 25-34.
11. Cardenosa, N., Dominguez, A., Orcau, A., Panella, H., Godoy, P., Minguell, S., Camps, N. & Vazquez, J. A. (2001). Carriers of Neisseria meningitidis in household contacts of meningococcal disease cases in Catalonia (Spain). Eur J Epidemiol 17, 877-884.
12. Cartwright, K. (1995). Meningococcal carriage and disease. In Meningococcal Disease, pp. 115-146. Edited by K. Cartwright. Chichester, UK: Wiley & Sons.
13. Cartwright, K. A., Stuart, J. M., Jones, D. M. & Noah, N. D. (1987). The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica. Epidemiol Infect 99, 591-601.
14. Caugant, D. A. (1998). Population genetics and molecular epidemiology of Neisseria meningitidis. APMIS 106, 505-525.
15. Caugant, D. A., Kristiansen, B. E., Frøholm, L O., Bøvre, K. & Selander, R. K. (1988). Clonal diversity of Neisseria meningitidis from a population of asymptomatic carriers. Infect Immun 56, 2060-2068.
16. Caugant, D. A., Høiby, E. A., Rosenqvist, E., Frøholm, L. O. & Selander, R. K. (1992). Transmission of Neisseria meningitidis among asymptomatic military recruits and antibody analysis. Epidemiol Infect 109, 241-253.
17. Caugant, D. A., Høiby, E. A., Magnus, P., Scheel, O., Hoel, T., Bjune, G., Wedege, E., Eng, J. & Frøholm, L. O. (1994). Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population. J Clin Microbiol 32, 323-330.
18. Claus, H., Swiderek, H., Frosch, M. & Vogel, U. (2002a). Meningococcal sequence typing using microarrays. In Abstracts of the 13th International Pathogenic Neisseria Conference, abstract 341. Edited by D. A. Caugant & E. Wedege. Oslo: Norwegian Institute of Public Health.
19. Claus, H., Maiden, M. C., Maag, R., Frosch, M. & Vogel, U. (2002b). Many carried meningococci lack the genes required for capsule synthesis and transport. Microbiology 148, 1813-1819.
20. Claus, H., Borrow, R., Achtman, M., Morelli, G., Kantelberg, C., Longworth, E., Frosch, M. & Vogel, U. (2004). Genetics of capsule O-acetylation in serogroup C, W-135 and Y meningococci. Mol Microbiol 51, 227-239.
21. Cooke, R. P., Riordan, T., Jones, D. M. & Painter, M. J. (1989). Secondary cases of meningococcal infection among close family and household contacts in England and Wales, 1984-7. BMJ 298, 555-558.
22. Cunningham, R., Mathews, R., Lewendon, G., Harrison, S. & Stuart, J. M. (2001). Improved rate of isolation of Neisseria meningitidis by direct plating of pharyngeal swabs. J Clin Microbiol 39, 4575-4576.
23. D'Amelio, R., Agostoni, A., Biselli, R. & 7 other authors (1992). Complement deficiency and antibody profile in survivors of meningococcal meningitis due to common serogroups in Italy. Scand J Immunol 35, 589-595.
24. Davidsen, T., Rodland, E. A., Lagesen, K., Seeberg, E., Rognes, T. & Tonjum, T. (2004). Biased distribution of DNA uptake sequences towards genome maintenance genes. Nucleic Acids Res 32, 1050-1058.
25. Davies, A. L., O'Flanagan, D., Salmon, R. L. & Coleman, T. J. (1996). Risk factors for Neisseria meningitidis carriage in a school during a community outbreak of meningococcal infection. Epidemiol Infect 117, 259-266.
26. Deal, W. B. & Sanders, E. (1969). Efficacy of rifampin in treatment of meningococcal carriers. N Engl J Med 281, 641-645.
27. Deghmane, A. E., Petit, S., Topilko, A., Pereira, Y., Giorgini, D., Larribe, M. & Taha, M. K. (2000). Intimate adhesion of Neisseria meningitidis to human epithelial cells is under the control of the crgA gene, a novel LysR-type transcriptional regulator. EMBO J 19, 1068-1078.
28. Deghmane, A. E., Giorgini, D., Larribe, M., Alonso, J. M. & Taha, M. K. (2002). Down-regulation of pili and capsule of Neisseria meningitidis upon contact with epithelial cells is mediated by CrgA regulatory protein. Mol Microbiol 43, 1555-1564.
29. Dehio, C., Gray-Owen, S. D. & Meyer, T. F. (1998). The role of neisserial Opa proteins in interactions with host cells. Trends Microbiol 6, 489-495.
30. Dillon, J. R., Pauze, M. & Yeung, K. H. (1983). Spread of penicillinase-producing and transfer plasmids from the gonococcus to Neisseria meningitidis. Lancet 1, 779-781.
31. Di Martino, M., Cali, G., Astorre, P., Usai, G. C., Ferrari, R. & Stroffolini, T. (1990). Meningococcal carriage and vaccination in army recruits in Italy. Boll Ist Sieroter Milan 69, 357-359.
32. Djupesland, P., Bjune, G., Aanosen, N. O., Borchgrevink, H. M., Mundal, R. & Høiby, E. A. (1990). Systemic menningococcal disease in the Norwegian Army. Nord Med 105, 179-181 (in Norwegian).
33. Dolan-Livengood, J. M., Miller, Y. K., Martin, L. E., Urwin, R. & Stephens, D. S. (2003). Genetic basis for nongroupable Neisseria meningitidis. J Infect Dis 187, 1616-1628.
34. Edwards, U., Muller, A., Hammerschmidt, S., Gerardy-Schahn, R. & Frosch, M. (1994). Molecular analysis of the biosynthesis pathway of the α-2,8 polysialic acid capsule by Neisseria meningitidis serogroup B. Mol Microbiol 14, 141-149.
35. Fairley, C. K., Begg, N., Borrow, R., Fox, A. J., Jones, D. M. & Cartwright, K. (1996). Conjugate meningococcal serogroup A and C vaccine: reactogenicity and immunogenicity in United Kingdom infants. J Infect Dis 174, 1360-1363.
36. Feil, E. J., Maiden, M. C., Achtman, M. & Spratt, B. G. (1999). The relative contributions of recombination and mutation to the divergence of clones of Neisseria meningitidis. Mol Biol Evol 16, 1496-1502.
37. Fermer, C. & Swedberg, G. (1997). Adaptation to sulfonamide resistance in Neisseria meningitidis may have required compensatory changes to retain enzyme function: kinetic analysis of dihydropteroate synthases from N. meningitidis expressed in a knockout mutant of Escherichia coli. J Bacteriol 179, 831-837.
38. Fermer, C., Kristiansen, B. E., Sköld, O. & Swedberg, G. (1995). Sulfonamide resistance in Neisseria meningitidis as defined by site-directed mutagenesis could have its origin in other species. J Bacteriol 177, 4669-4675.
39. Fernandez, S., Arreaza, L., Santiago, I., Malvar, A., Berron, S., Vazquez, J. A. & Hervada, X. (2003). Impact of meningococcal vaccination with combined serogroups A and C polysaccharide vaccine on carriage of Neisseria meningitidis C. J Med Microbiol 52, 75-77.
40. Fijen, C. A., Kuijper, E. J., Hannema, A. J., Sjöholm, A. G. & van Putten, J. P. (1989). Complement deficiencies in patients over ten years old with meningococcal disease due to uncommon serogroups. Lancet 2, 585-588.
41. Frasch, C. E., Zollinger, W. D. & Poolman, J. T. (1985). Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. Rev Infect Dis 7, 504-510.
42. Frosch, M. & Muller, A. (1993). Phospholipid substitution of capsular polysaccharides and mechanisms of capsule formation in Neisseria meningitidis. Mol Microbiol 8, 483-493.
43. Frosch, M., Weisgerber, C. & Meyer, T. F. (1989). Molecular characterization and expression in Escherichia coli of the gene complex encoding the polysaccharide capsule of Neisseria meningitidis group B. Proc Natl Acad Sci U S A 86, 1669-1673.
44. Frosch, M., Edwards, U., Bousset, K., Krausse, B. & Weisgerber, C. (1991). Evidence for a common molecular origin of the capsule gene loci in gram-negative bacteria expressing group II capsular polysaccharides. Mol Microbiol 5, 1251-1263.
45. Frosch, M., Muller, D., Bousset, K. & Muller, A. (1992). Conserved outer membrane protein of Neisseria meningitidis involved in capsule expression. Infect Immun 60, 798-803.
46. Gotschlich, E. C., Goldschneider, I. & Artenstein, M. S. (1969). Human immunity to the meningococcus. V. The effect of immunization with meningococcal group C polysaccharide on the carrier state. J Exp Med 129, 1385-1395.
47. Gray-Owen, S. D. & Schryvers, A. B. (1996). Bacterial transferrin and lactoferrin receptors. Trends Microbiol 4, 185-191.
48. Griffiss, J. M. (1995). Mechanism of host immunity. In Meningococcal Disease, pp. 36-70. Edited by K. Cartwright. Chichester, UK: Wiley & Sons.
49. Griffiss, J. M., Schneider, H., Mandrell, R. E., Yamasaki, R., Jarvis, G. A., Kim, J. J., Gibson, B. W., Hamadeh, R. & Apicella, M. A. (1988). Lipooligosaccharides: the principal glycolipids of the neisserial outer membrane. Rev Infect Dis 10, S287-S295.
50. Hammerschmidt, S., Birkholz, C., Zahringer, U., Robertson, B. D., van Putten, J., Ebeling, O. & Frosch, M. (1994). Contribution of genes from the capsule gene complex (cps) to lipooligosaccharide biosynthesis and serum resistance in Neisseria meningitidis. Mol Microbiol 11, 885-896.
51. Hammerschmidt, S., Muller, A., Sillmann, H. & 7 other authors (1996). Capsule phase variation in Neisseria meningitidis serogroup B by slipped-strand mispairing in the polysialyltransferase gene (siaD): correlation with bacterial invasion and the outbreak of meningococcal disease. Mol Microbiol 20, 1211-1220.
52. Hassan-King, M. K., Wall, R. A. & Greenwood, B. M. (1988). Meningococcal carriage, meningococcal disease and vaccination. J Infect 16, 55-59.
53. Hitchcock, P. J. (1989). Unified nomenclature for pathogenic Neisseria species. Clin Microbiol Rev 2 (Suppl.), S64-S65.
54. Hobbs, M. M., Seiler, A., Achtman, M. & Cannon, J. G. (1994). Microevolution within a clonal population of pathogenic bacteria: recombination, gene duplication and horizontal genetic exchange in the opa gene family of Neisseria meningitidis. Mol Microbiol 12, 171-180.
55. Jackson, L. A., Alexander, E. R., Debolt, C. A., Swenson, P. D., Boase, J., McDowell, M. G., Reeves, M. W. & Wenger, J. D. (1996). Evaluation of the mass chemoprophylaxis during a school outbreak of enzyme type 5 serogroup B meningococcal disease. Pediatr Infect Dis J 15, 992-998.
56. Jodar, L., Feavers, I. M., Salisbury, D. & Granoff, D. M. (2002). Development of vaccines against meningococcal disease. Lancet 359, 1499-1508.
57. Johansson, L., Rytkonen, A., Bergman, P., Albiger, B., Källström, H., Hokfelt, T., Agerberth, B., Cattaneo, R. & Jonsson, A. B. (2003). CD46 in meningococcal disease. Science 301, 373-375.
58. Jolley, K. A., Kalmusova, J., Feil, E. J., Gupta, S., Musilek, M., Kriz, P. & Maiden, M. C. (2000). Carried meningococci in the Czech Republic: a diverse recombining population. J Clin Microbiol 38, 4492-4498.
59. Jones, G. R., Christodoulides, M., Brooks, J. L., Miller, A. R., Cartwright, K. A. & Heckels, J. E. (1998). Dynamics of carriage of Neisseria meningitidis in a group of military recruits: subtype stability and specificity of the immune response following colonization. J Infect Dis 178, 451-459.
60. Jordens, J. Z., Williams, J. N., Jones, G. R. & Heckels, J. E. (2002). Detection of meningococcal carriage by culture and PCR of throat swabs and mouth gargles. J Clin Microbiol 40, 75-79.
61. Kahler, C. M. & Stephens, D. S. (1998). Genetic basis for biosynthesis, structure, and function of meningococcal lipooligosaccharide (endotoxin). Crit Rev Microbiol 24, 281-334.
62. Källström, H., Liszewski, M. K., Atkinson, J. P. & Jonsson, A. B. (1997). Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria. Mol Microbiol 25, 639-647.
63. Källström, H., Islam, M. S., Berggren, P. O. & Jonsson, A. B. (1998). Cell signaling by the type IV pili of pathogenic Neisseria. J Biol Chem 273, 21777-21782.
64. Kilian, M., Reinholdt, J., Lomholt, H., Poulsen, K. & Frandsen, E. V. (1996). Biological significance of IgA1 proteases in bacterial colonization and pathogenesis: critical evaluation of experimental evidence. APMIS 104, 321-338.
65. Koomey, M. (2001). Implications of molecular contacts and signaling initiated by Neisseria gonorrhoeae. Curr Opin Microbiol 4, 53-57.
66. Kremastinou, J., Tzanakaki, G., Pagalis, A., Theodondou, M., Weir, D. M. & Blackwell, C. C. (1999). Detection of IgG and IgM to meningococcal outer membrane proteins in relation to carriage of Neisseria meningitidis or Neisseria lactamica. FEMS Immunol Med Microbiol 24, 73-78.
67. Kremastinou, J., Tzanakaki, G., Levidiotou, S., Markou, F., Themeli, E., Voyiatzi, A., Psoma, E., Theodoridou, M. & Blackwell, C. C. (2003). Carriage of Neisseria meningitidis and Neisseria lactamica in northern Greece. FEMS Immunol Med Microbiol 39, 23-29.
68. Kroll, J. S., Wilks, K. E., Farrant, J. L. & Langford, P. R. (1998). Natural genetic exchange between Haemophilus and Neisseria: intergeneric transfer of chromosomal genes between major human pathogens. Proc Natl Acad Sci U S A 95, 12381-12385.
69. Larson, J. A., Higashi, D. L., Stojiljkovic, I. & So, M. (2002). Replication of Neisseria meningitidis within epithelial cells requires TonB-dependent acquisition of host cell iron. Infect Immun 70, 1461-1467.
70. Linz, B., Schenker, M., Zhu, P. & Achtman, M. (2000). Frequent interspecific genetic exchange between commensal neisseriae and Neisseria meningitidis. Mol Microbiol 36, 1049-1058.
71. Lomholt, H., Poulsen, K., Caugant, D. A. & Kilian, M. (1992). Molecular polymorphism and epidemiology of Neisseria meningitidis immunoglobulin A1 proteases. Proc Natl Acad Sci U S A 89, 2120-2124.
72. Maiden, M. C., Suker, J., McKenna, A. J., Bygraves, J. A. & Feavers, I. M. (1991). Comparison of the class 1 outer membrane proteins of eight serological reference strains of Neisseria meningitidis. Mol Microbiol 5, 727-736.
73. Maiden, M. C., Bygraves, J. A., McCarvil, J. & Feavers, I. M. (1992). Identification of meningococcal serosubtypes by polymerase chain reaction. J Clin Microbiol 30, 2835-2841.
74. Maiden, M. C., Bygraves, J. A., Feil, E. & 10 other authors (1998). Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci USA 95, 3140-3145.
75. Maiden, M. C. J., Stuart, J. M., Bramley, J. C., MacLennan, J. M., Gray, S. & Andrew, N. (2002). Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination. Lancet 359, 1829-1831.
76. McGuinness, B., Barlow, A. K., Clarke, I. N., Farley, J. E., Anilionis, A., Poolman, J. T. & Heckels, J. E. (1990). Deduced amino acid sequences of class 1 protein (PorA) from three strains of Neisseria meningitidis. Synthetic peptides define the epitopes responsible for serosubtype specificity. J Exp Med 171, 1871-1882.
77. Mendelman, P. M., Campos, J., Chaffin, D. O., Serfass, D. A., Smith, A. L. & Saez-Nieto, J. A. (1988). Relative penicillin G resistance in Neisseria meningitidis and reduced affinity of penicillin-binding protein 3. Antimicrob Agents Chemother 32, 706-709.
78. Merz, A. J. & So, M. (2000). Interactions of pathogenic neisseriae with epithelial cell membranes. Annu Rev Cell Dev Biol 16, 423-457.
79. Merz, A. J., Rifenbery, D. B., Arvidson, C. G. & So, M. (1996). Traversal of a polarized epithelium by pathogenic Neisseriae: facilitation by type IV pili and maintenance of epithelial barrier function. Mol Med 2, 745-754.
80. Merz, A. J., Enns, C. A. & So, M. (1999). Type IV pili of pathogenic Neisseriae elicit cortical plaque formation in epithelial cells. Mol Microbiol 32, 1316-1332.
81. Merz, A. J., So, M. & Sheetz, M. P. (2000). Pilus retraction powers bacterial twitching motility. Nature 407, 98-102.
82. Neal, K. R., Nguyen-Van-Tam, J. S., Jeffrey, N., Slack, R. C., Madeley, R. J., Ait-Tahar, K., Job, K., Wale, M. C. & Ala'Aldeen, D. A. (2000). Changing carriage rate of Neisseria meningitidis among university students during the first week of term: cross sectional study. BMJ 320, 846-849.
83. Nolte, O. (1997). Rifampicin resistance in Neisseria meningitidis: evidence from a study of sibling strains, description of new mutations and notes on population genetics. J Antimicrob Chemother 39, 747-755.
84. Nurkka, A., MacLennan, J., Jantti, V., Obaro, S., Greenwood, B. & Kayhty, H. (2000). Salivary antibody response to vaccination with meningococcal A/C polysaccharide vaccine in previously vaccinated and unvaccinated Gambian children. Vaccine 19, 547-556.
85. Olcén, P., Kjellander, J., Danielsson, D. & Lindquist, B. L. (1981). Epidemiology of Neisseria meningitidis; prevalence and symptoms from the upper respiratory tract in family members to patients with meningococcal disease. Scand J Infect Dis 13, 105-109.
86. Oppenheim, B. A. (1997). Antibiotic resistance in Neisseria meningitidis. Clin Infect Dis 24, (Suppl. 1), S98-S101.
87. Pohlner, J., Klauser, T., Kuttler, E. & Halter, R. (1992). Sequence-specific cleavage of protein fusions using a recombinant Neisseria type 2 IgA protease. Biotechnology (N Y) 10, 799-804.
88. Pollard, A. J. & Frasch, C. (2001). Development of natural immunity to Neisseria meningitidis. Vaccine 19, 1327-1346.
89. Poolman, J. T., van Der Ley, P. A. & Tommassen, J. (1995). Surface structure and secreted products of meningococci. In Meningococcal Disease, pp. 21-34. Edited by K. Cartwright. Chichester, UK: Wiley & Sons.
90. Porat, N., Apicella, M. A. & Blake, M. S. (1995). A lipooligosaccharide-binding site on HepG2 cells similar to the gonococcal opacity-associated surface protein Opa. Infect Immun 63, 2164-2172.
91. Pujol, C., Eugene, E., Marceau, M. & Nassif, X. (1999). The meningococcal PilT protein is required for induction of intimate attachment to epithelial cells following pilus-mediated adhesion. Proc Natl Acad Sci U S A 96, 4017-4022.
92. Reller, L. B., MacGregor, R. R. & Beaty, H. N. (1973). Bactericidal antibody after colonization with Neisseria meningitidis. J Infect Dis 127, 56-62.
93. Roberts, M. C. & Knapp, J. S. (1988). Transfer of β-lactamase plasmids from Neisseria gonorrhoeae to Neisseria meningitidis and commensal Neisseria species by the 25.2-megadalton conjugative plasmid. Antimicrob Agents Chemother 32, 1430-1432.
94. Robinson, K., Neal, K. R., Howard, C. & 11 other authors (2002). Characterization of humoral and cellular immune responses elicited by meningococcal carriage. Infect Immun 70, 1301-1309.
95. Rosenqvist, E., Bjune, G., Feiring, B., Eng, J., Frøholm, L. O., Høiby, A., Moe, B. & Nøkleby, H. (1994). Changes in carrier status of Neisseria meningitidis in teenagers during a group B outer membrane vaccination trial in Norway. In Abstracts of the 8th International Pathogenic Neisseria Conference, pp. 895-901. Edited by C. J. Conde-Glez, S. Morse, P. Rice, F. Sparling & E. Calderon. Mexico: Insituto National de Salud Publica-Morelos-Mexico.
96. Ross, S. C. & Densen, P. (1984). Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency. Medicine (Baltimore) 63, 243-273.
97. Sadler, F., Fox, A., Neal, K., Dawson, M., Cartwright, K. & Borrow, R. (2003). Genetic analysis of capsular status of meningococcal carrier isolates. Epidemiol Infect 130, 59-70.
98. Saez-Nieto, J. A., Lujan, R., Martinez-Suarez, J. V., Berron, S., Vazquez, J. A., Vinas, M. & Campos, J. (1990). Neisseria lactamica and Neisseria polysaccharea as possible sources of meningococcal β-lactam resistance by genetic transformation. Antimicrob Agents Chemother 34, 2269-2272.
99. Sanchez, S., Troncoso, G., Ferreiros, C. M. & Criado, M. T. (2001). Evaluation of cross-reactive antigens as determinants of cross-bactericidal activity in pathogenic and commensal Neisseria. Vaccine 19, 3390-3398.
100. Sanchez, S., Troncoso, G., Criado, M. T. & Ferreiros, C. (2002). In vitro induction of memory-driven responses against Neisseria meningitidis by priming with Neisseria lactamica. Vaccine 20, 2957-2963.
101. Schryvers, A. B. & Stojiljkovic, I. (1999). Iron acquisition systems in the pathogenic Neisseria. Mol Microbiol 32, 1117-1123.
102. Sim, R. J., Harrison, M. M., Moxon, E. R. & Tang, C. M. (2000). Underestimation of meningococci in tonsillar tissue by nasopharyngeal swabbing. Lancet 356, 1653-1654.
103. Simmons, G., Jones, N. & Calder, L. (2000). Equivalence of ceftriaxone and rifampicin in eliminating nasopharyngeal carriage of serogroup B Neisseria meningitidis. J Antimicrob Chemother 45, 909-911.
104. Simmons, G., Martin, D., Stewart, J., Jones, N., Calder, L. & Bremner, D. (2001). Carriage of Neisseria meningitidis among household contacts of patients with meningococcal disease in New Zealand. Eur J Clin Microbiol Infect Dis 20, 237-242.
105. Smith, H. O., Gwinn, M. L. & Salzberg, S. L. (1999). DNA uptake signal sequences in naturally transformable bacteria. Res Microbiol 150, 603-616.
106. Snyder, L. A., Butcher, S. A. & Saunders, N. J. (2001). Comparative whole-genome analyses reveal over 100 putative phase-variable genes in the pathogenic Neisseria spp. Microbiology 147, 2321-2332.
107. Stefanelli, P., Fazio, C., La Rosa, G., Marianelli, C., Muscillo, M. & Mastrantonio, P. (2001). Rifampicin-resistant meningococci causing invasive disease: detection of point mutations in the rpoB gene and molecular characterization of the strains. J Antimicrob Chemother 47, 219-222.
108. Stephens, D. S. (1999). Uncloaking the meningococcus: dynamics of carriage and disease. Lancet 353, 941-942.
109. Stuart, J. M., Cartwright, K. A., Dawson, J. A., Rickard, J. & Noah, N. D. (1988). Risk factors for meningococcal disease: a case control study in south west England. Community Med 10, 139-146.
110. Stuart, J. M., Cartwright, K. A., Robinson, P. M. & Noah, N. D. (1989). Effect of smoking on meningococcal carriage. Lancet 2, 723-725.
111. Swartley, J. S., Martin, A. A., Edupuganti, S., Liu, L. J., Cieslak, P., Perkins, B., Wenger, J. D. & Stephens, D. S. (1997). Capsule switching of Neisseria meningitidis. Proc Natl Acad Sci U S A 94, 271-276.
112. Swartley, J. S., Liu, L. J., Miller, Y. K., Martin, L. E., Edupuganti, S. & Stephens, D. S. (1998). Characterization of the gene cassette required for biosynthesis of the (α→6) -linked N-acetyl-D-mannosamine-1- phosphate capsule of serogroup A Neisseria meningitidis. J Bacteriol 180, 1533-1539.
113. Taha, M. K., Morand, P. C., Pereira, Y., Eugene, E., Giorgini, D., Larribe, M. & Nassif, X. (1998). Pilus-mediated adhesion of Neisseria meningitidis: the essential role of cell contact-dependent transcriptional upregulation of the PilC1 protein. Mol Microbiol 28, 1153-1163.
114. Tommassen, J., Vermeij, P., Struyve, M., Benz, R. & Poolman, J. T. (1990). Isolation of Neisseria meningitidis mutants deficient in class 1 (porA) and class 3 (porB) outer membrane proteins. Infect Immun 58, 1355-1359.
115. Tonjum, T., Caugant, D. A., Dunham, S. A. & Koomey, M. (1998). Structure and function of repetitive sequence elements associated with a highly polymorphic domain of the Neisseria meningitidis PilQ protein. Mol Microbiol 29, 111-124.
116. Troncoso, G., Sanchez, S., Moreda, M., Criado, M. T. & Ferreiros, C. M. (2000). Antigenic cross-reactivity between outer membrane proteins of Neisseria meningitidis and commensal Neisseria species. FEMS Immunol Med Microbiol 27, 103-109.
117. Troncoso, G., Sanchez, S., Kolberg, J., Rosenqvist, E., Veiga, M., Ferreiros, C. M. & Criado, M. (2001). Analysis of the expression of the putatively virulence-associated neisserial protein RmpM (class 4) in commensal Neisseria and Moraxella catarrhalis strains. FEMS Microbiol Lett 199, 171-176.
118. Tsai, C. M., Frasch, C. E. & Mocca, L. F. (1981). Five structural classes of major outer membrane proteins in Neisseria meningitidis. J Bacteriol 146, 69-78.
119. Tunkel, A. R. & Scheld, W. M. (1993). Pathogenesis and pathophysiology of bacterial meningitis. Clin Microbiol Rev 6, 118-136.
120. Tyski, S., Grzybowska, W., Dulny, G., Berthelsen, L. & Lind, I. (2001). Phenotypical and genotypical characterization of Neisseria meningitidis carrier strains isolated from Polish recruits in 1998. Eur J Clin Microbiol Infect Dis 20, 350-353.
121. Tzeng, Y. L. & Stephens, D. S. (2000). Epidemiology and pathogenesis of Neisseria meningitidis. Microbes Infect 2, 687-700.
122. Urwin, R., Holmes, E. C., Fox, A. J., Derrick, J. P. & Maiden, M. C. (2002). Phylogenetic evidence for frequent positive selection and recombination in the meningococcal surface antigen PorB. Mol Biol Evol 19, 1686-1694.
123. van der Ende, A., Hopman, C. T. & Dankert, J. (2000). Multiple mechanisms of phase variation of PorA in Neisseria meningitidis. Infect Immun 68, 6685-6690.
124. Virji, M., Makepeace, K., Ferguson, D. J., Achtman, M. & Moxon, E. R. (1993). Meningococcal Opa and Opc proteins: their role in colonization and invasion of human epithelial and endothelial cells. Mol Microbiol 10, 499-510.
125. Virji, M., Makepeace, K. & Moxon, E. R. (1994). Distinct mechanisms of interactions of Opc-expressing meningococci at apical and basolateral surfaces of human endothelial cells; the role of integrins in apical interactions. Mol Microbiol 14, 173-184.
126. Vitovski, S., Read, R. C. & Sayers, J. R. (1999). Invasive isolates of Neisseria meningitidis possess enhanced immunoglobulin A1 protease activity compared to colonizing strains. FASEB J 13, 331-337.
127. Vogel, U., Claus, H. & Frosch, M. (2001). Capsule operons. In Meningococcal Disease, Methods and Protocols, pp. 187-201. Edited by A. J. Pollard & M. C. Maiden. Totowa, NJ: Humana Press.
128. Weichselbaum, A. (1887). Über die aetiologie der akuten meningitis cerebro-spinalis. Fortschr Med 5, 573-583.
129. Wilder-Smith, A., Barkham, T. M., Earnest, A. & Paton, N. I. (2002). Acquisition of W135 meningococcal carriage in Hajj pilgrims and transmission to household contacts: prospective study. BMJ 325, 365-366.
130. Wolfgang, M., van Putten, J. P., Hayes, S. F., Dorward, D. & Koomey, M. (2000). Components and dynamics of fiber formation define a ubiquitous biogenesis pathway for bacterial pili. EMBO J 19, 6408-6418.
131. Yagupsky, P., Ashkenazi, S. & Block, C. (1993). Rifampicin-resistant meningococci causing invasive disease and failure of chemoprophylaxis. Lancet 341, 1152-1153.
132. Yoshino, T., Tanaka, T., Takeyama, H. & Matsunaga, T. (2003). Single nucleotide polymorphism genotyping of aldehyde dehydrogenase 2 gene using a single bacterial magnetic particle. Biosens Bioelectron 18, 661-666.
133. Young, L. S., LaForce, F. M., Head, J. J., Feeley, J. C. & Bennett, J. V. (1972). A simultaneous outbreak of meningococcal and influenza infection. N Engl J Med 287, 5-9.
134. Zagursky, R. J., Olmsted, S. B., Russell, D. P. & Wooters, J. L. (2003). Bioinformatics: how it is being used to identify bacterial vaccine candidates. Expert Rev Vaccines 2, 417-436.
135. Zhang, Q., Choo, S., Everard, J., Jennings, R. & Finn, A. (2000). Mucosal immune responses to meningococcal group C conjugate and group A and C polysaccharide vaccines in adolescents. Infect Immun 68, 2692-2697.
136. Zhu, P., Hu, X. & Xu, L. (1995). Typing Neisseria meningitidis by analysis of restriction fragment length polymorphisms in the gene encoding the class 1 outer membrane protein: application to assessment of epidemics throughout the last 4 decades in China. J Clin Microbiol 33, 458-462.
137. Zhu, P., Klutch, M. J., Bash, M. C., Tsang, R. S., Ng, L. K. & Tsai, C. M. (2002). Genetic diversity of three lgt loci for biosynthesis of lipooligosaccharide (LOS) in Neisseria species. Microbiology 148, 1833-1844.
138. Zollinger, W. D. & Mandrell, R. E. (1977). Outer-membrane protein and lipopolysaccharide serotyping of Neisseria meningitidis by inhibition of a solid-phase radioimmunoassay. Infect Immun 18, 424-433.
139. Zollinger, W. D. & Mandrell, R. E. (1980). Type-specific antigens of group A Neisseria meningitidis: lipopolysaccharide and heat-modifiable outer membrane proteins. Infect Immun 28, 451-458.